Factors affecting the Turnaround Time for Manufacturing, Testing and Release of Cellular Therapy Products prepared at Multiple Sites in support of Multicenter Cardiovascular Regenerative Medicine Protocols – a Cardiovascular Cell Therapy Research Network (CCTRN) Study

BACKGROUND: Cellular therapy studies are often conducted at multiple clinical sites in order to accrue larger patient numbers. In many cases this necessitates use of localized Good Manufacturing Practices (GMP) facilities to supply the cells. To assure consistent quality, oversight by a quality assu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Richman, Sara, Gee, Adrian P., McKenna, David, Traverse, Jay, Henry, Timothy, Fisk, Diann, Pepine, Carl, Bloom, Jeannette, Willerson, James, Prater, Karen, Zhao, David, Koç, Jane Reese, Anwaruddian, Saif, Taylor, Doris, Cogle, Christopher, Moyé, Lemuel, Simari, Robert, Skarlatos, Sonia
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3355200/
https://ncbi.nlm.nih.gov/pubmed/22320233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1537-2995.2011.03543.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi